|
Volumn 59, Issue 7, 2013, Pages 253-260
|
Management of multiple sclerosis: An overview
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA1A INTERFERON;
FINGOLIMOD;
GLATIRAMER;
INTERFERON BETA SERINE;
MITOXANTRONE;
NATALIZUMAB;
TERIFLUNOMIDE;
ACUTE GRANULOCYTIC LEUKEMIA;
ALOPECIA;
AMENORRHEA;
ANAPHYLAXIS;
ANEMIA;
ANXIETY;
ARTHRALGIA;
BACKACHE;
BLADDER DYSFUNCTION;
CARDIOTOXICITY;
CHEST TIGHTNESS;
CHILL;
COUGHING;
DEPRESSION;
DIARRHEA;
DRUG EFFICACY;
DRUG MECHANISM;
DYSPNEA;
EXTRAVASATION;
FATIGUE;
FEVER;
FLU LIKE SYNDROME;
FLUSHING;
FOLLOW UP;
GASTROINTESTINAL SYMPTOM;
HAIR LOSS;
HEADACHE;
HEART PALPITATION;
HERPES SIMPLEX;
HUMAN;
IMMUNOMODULATION;
INFLUENZA;
INJECTION SITE EDEMA;
INJECTION SITE ERYTHEMA;
INJECTION SITE PAIN;
INJECTION SITE PRURITUS;
INJECTION SITE REACTION;
LEUKOPENIA;
LIVER FUNCTION;
LIVER FUNCTION TEST;
LONG TERM CARE;
MULTIPLE SCLEROSIS;
MYALGIA;
NAUSEA;
NEUTROPENIA;
OUTCOME ASSESSMENT;
PNEUMONIA;
RESPIRATORY TRACT INFECTION;
REVIEW;
SIDE EFFECT;
SPASTICITY;
THORAX PAIN;
THROMBOCYTOPENIA;
TREATMENT INDICATION;
URINARY TRACT INFECTION;
URTICARIA;
DISEASE MANAGEMENT;
DRUG MONITORING;
HUMANS;
IMMUNOLOGIC FACTORS;
IMMUNOMODULATION;
MEDICATION THERAPY MANAGEMENT;
MULTIPLE SCLEROSIS;
RECURRENCE;
TREATMENT OUTCOME;
|
EID: 84879179042
PISSN: 00115029
EISSN: 15578194
Source Type: Journal
DOI: 10.1016/j.disamonth.2013.03.012 Document Type: Review |
Times cited : (14)
|
References (3)
|